149 related articles for article (PubMed ID: 30391539)
41. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
[TBL] [Abstract][Full Text] [Related]
42. Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin.
Haugabook SJ; Le T; Yager D; Zenk B; Healy BM; Eckman EA; Prada C; Younkin L; Murphy P; Pinnix I; Onstead L; Sambamurti K; Golde TE; Dickson D; Younkin SG; Eckman CB
FASEB J; 2001 Jan; 15(1):16-18. PubMed ID: 11099491
[TBL] [Abstract][Full Text] [Related]
43. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
[TBL] [Abstract][Full Text] [Related]
44. Phosphorylation of the amyloid β-peptide at Ser26 stabilizes oligomeric assembly and increases neurotoxicity.
Kumar S; Wirths O; Stüber K; Wunderlich P; Koch P; Theil S; Rezaei-Ghaleh N; Zweckstetter M; Bayer TA; Brüstle O; Thal DR; Walter J
Acta Neuropathol; 2016 Apr; 131(4):525-37. PubMed ID: 26898910
[TBL] [Abstract][Full Text] [Related]
45. Differently selected D-enantiomeric peptides act on different Abeta species.
Bartnik D; Funke SA; Andrei-Selmer LC; Bacher M; Dodel R; Willbold D
Rejuvenation Res; 2010; 13(2-3):202-5. PubMed ID: 19954333
[TBL] [Abstract][Full Text] [Related]
46. A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer disease.
Hori Y; Takeda S; Cho H; Wegmann S; Shoup TM; Takahashi K; Irimia D; Elmaleh DR; Hyman BT; Hudry E
J Biol Chem; 2015 Jan; 290(4):1966-78. PubMed ID: 25468905
[TBL] [Abstract][Full Text] [Related]
47. The role of amyloid β in the pathogenesis of Alzheimer's disease.
Gilbert BJ
J Clin Pathol; 2013 May; 66(5):362-6. PubMed ID: 23526599
[TBL] [Abstract][Full Text] [Related]
48. New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.
Cisternas P; Zolezzi JM; Lindsay C; Rivera DS; Martinez A; Bozinovic F; Inestrosa NC
J Alzheimers Dis; 2018; 66(3):1145-1163. PubMed ID: 30412496
[TBL] [Abstract][Full Text] [Related]
49. [Constructing Brain Aβ-Targeting Nanoparticles Loaded with EGCG for Treating Alzheimer's Disease in Mice].
Yang P; Guo Q; Xu ST; Sheng DY; Zhang QZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):605-611. PubMed ID: 34323038
[TBL] [Abstract][Full Text] [Related]
50. Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis.
Chiang ACA; Fowler SW; Reddy R; Pletnikova O; Troncoso JC; Sherman MA; Lesne SE; Jankowsky JL
Am J Pathol; 2018 Mar; 188(3):739-756. PubMed ID: 29248459
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of amyloid Aβ aggregation by high pressures or specific d-enantiomeric peptides.
Cavini IA; Munte CE; Erlach MB; van Groen T; Kadish I; Zhang T; Ziehm T; Nagel-Steger L; Kutzsche J; Kremer W; Willbold D; Kalbitzer HR
Chem Commun (Camb); 2018 Mar; 54(26):3294-3297. PubMed ID: 29537428
[TBL] [Abstract][Full Text] [Related]
52. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
53. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D
J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337
[TBL] [Abstract][Full Text] [Related]
54. Synaptotoxic amyloid-β oligomers: a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease?
Klein WL
J Alzheimers Dis; 2013; 33 Suppl 1():S49-65. PubMed ID: 22785404
[TBL] [Abstract][Full Text] [Related]
55. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
[TBL] [Abstract][Full Text] [Related]
56. Decoding the synaptic dysfunction of bioactive human AD brain soluble Aβ to inspire novel therapeutic avenues for Alzheimer's disease.
Li S; Jin M; Liu L; Dang Y; Ostaszewski BL; Selkoe DJ
Acta Neuropathol Commun; 2018 Nov; 6(1):121. PubMed ID: 30409172
[TBL] [Abstract][Full Text] [Related]
57. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
[TBL] [Abstract][Full Text] [Related]
58. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
Clausen A; Xu X; Bi X; Baudry M
J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
[TBL] [Abstract][Full Text] [Related]
59. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
[TBL] [Abstract][Full Text] [Related]
60. Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation.
Xu PX; Wang SW; Yu XL; Su YJ; Wang T; Zhou WW; Zhang H; Wang YJ; Liu RT
Behav Brain Res; 2014 May; 264():173-80. PubMed ID: 24512768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]